SEC Comment Letter for MYRIAD GENETICS INC (MYGN) (CIK 0000899923) (MYGN) — Mar 25, 2014
MYRIAD GENETICS INC (MYGN) (CIK 0000899923)
Date: March 25, 2014 · CIK: 0000899923 · Accession: 0000000000-14-014870
AI Filing Summary & Sentiment
File numbers found in text: 000-26642
Show Raw Text
March 25 , 201 4 Via E -mail Mr. James S. Evans Chief Financial Officer Myriad Genetics, Inc . 320 Wakara Way Salt Lake City, UT 84108 Re: Myriad Genetics, Inc . Form 10-K for the Fiscal Year Ended June 30, 2013 Filed August 14, 2013 File No. 000-26642 Dear Mr. Evans : We have completed our review of your filing. We remind you that our comment or change s to disclosure in response to our comment do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any pers on under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information in the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Joel Parker Joel Parker Accounting Branch Chief